4.7 Article

Challenges and Successes in Linking HIV-Infected Women to Care in the United States

期刊

CLINICAL INFECTIOUS DISEASES
卷 52, 期 -, 页码 S231-S237

出版社

OXFORD UNIV PRESS INC
DOI: 10.1093/cid/ciq047

关键词

-

资金

  1. Bristol-Myers Squibb, Positive Charge Initiative
  2. Bristol-Myers Squibb, Positive Charge
  3. Bristol-Myers Squibb
  4. MS
  5. GlaxoSmithKline
  6. Gilead
  7. Merck
  8. Tibotec

向作者/读者索取更多资源

Women currently account for 27% of new human immunodeficiency virus (HIV) infections in the United States, the majority of which are acquired through heterosexual transmission. In the United States, black and Latino persons are disproportionately affected by the HIV epidemic, a disparity that is most dramatically present among HIV-infected women. Many of these women face significant discrimination as a result of race or ethnicity and sex, and they suffer disproportionately from poverty, low health literacy, and lack of access to high-quality HIV care. As a consequence, despite the availability of highly active antiretroviral therapy (HAART), women with HIV often have delayed entry into care and experience poor outcomes. This article reviews risk factors for HIV infection in women, barriers to engagement in care, and strategies to improve linkage to HIV-related medical and social care.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据